Skip to main content
Clinical Trials/NCT02776956
NCT02776956
Completed
Not Applicable

Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy

xieruiqin1 site in 1 country180 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
atorvastatin group
Conditions
Atrial Fibrillation
Sponsor
xieruiqin
Enrollment
180
Locations
1
Primary Endpoint
Left atrial function of postoperative atrial fibrillation detected
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

A total of 120 patients with persistent atrial fibrillation (including continuous and long-standing persistent atrial fibrillation) and 60 patients with paroxysmal atrial fibrillation will receive radiofrequency ablation. Patients in each group will be randomly allocated into the statin treatment group and non-statin treatment group (allocation ratio, 1:1). Left atrial appendage flow velocity of all patients are measured by Transesophageal Echocardiography(TEE) 24 hours before the operation. Real-time ultrasound examinations of left atrial function are carried out for all patients before the operation and after the operation. Blood samples are extracted in all patients before the operation and after the operation. This study will clarify whether the application of statin drugs can improve postoperative left atrial function. This study will identify the time course and influence factors of left atrial recovery of atrial fibrillation after the operation to guide the time and the degree of anticoagulation and effectively prevent thromboembolic events. At the same time, biochemical indicators are detected to analyze which indicators are related to the postoperative recurrence of atrial fibrillation, the incidence of postoperative thrombosis and the recovery of postoperative left atrial function. Furthermore, this study will investigate whether the application of statin drugs can improve postoperative left atrial function by affecting these indicators.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
August 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
xieruiqin
Responsible Party
Sponsor Investigator
Principal Investigator

xieruiqin

director of cardiology department

The Second Hospital of Hebei Medical University

Eligibility Criteria

Inclusion Criteria

  • All persistent or permanent AF patients with refractory or intolerant to at least one Class 1 or Class 3 antiarrhythmic medication.
  • paroxysmal atrial fibrillation with refractory or intolerant to at least one Class 1 or Class 3 antiarrhythmic medication.
  • age is \<80 years

Exclusion Criteria

  • left ventricular dysfunction
  • LA \>50 mm
  • atrial thrombosis
  • valvular heart disease
  • hyperthyroidism
  • patients who underwent prosthetic heart valve replacement
  • patients with previous history of atrial fibrillation ablation
  • Hyperlipidemia
  • pregnant women
  • patients with existing liver and kidney disease

Arms & Interventions

atorvastatin group

atrial fibrillation in atorvastatin group will orally receive atorvastatin before and after operation.

Intervention: atorvastatin group

non-atorvastatin group

atrial fibrillation in non-atorvastatin group will not receive atorvastatin before and after operation..

Intervention: non-atorvastatin group

Outcomes

Primary Outcomes

Left atrial function of postoperative atrial fibrillation detected

Time Frame: 1-12 month

Secondary Outcomes

  • Plasma biomarkers of inflammation,myocardial injury and prothrombotic assessed(1-3 month)

Study Sites (1)

Loading locations...

Similar Trials